Department of Medical Sciences, Dermatology and Venereology, Uppsala University, Uppsala, Sweden.
J Invest Dermatol. 2011 Aug;131(8):1684-91. doi: 10.1038/jid.2011.93. Epub 2011 Apr 14.
Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by mutations in keratin genes (KRT5 or KRT14), with no existing therapies. Aggregates of misfolded mutant keratins are seen in cultured keratinocytes from severe EBS patients. In other protein-folding disorders, involvement of molecular chaperones and the ubiquitin-proteasome system may modify disease severity. In this study, the effects of heat stress on keratin aggregation in immortalized cells from two patients with EBS (KRT5) and a healthy control were examined with and without addition of various test compounds. Heat-induced (43 °C, 30 minutes) aggregates were observed in all cell lines, the amount of which correlated with the donor phenotype. In EBS cells pre-exposed to proteasome inhibitor, MG132, and p38-mitogen-activated protein kinase (MAPK) inhibitor, SB203580, the proportion of aggregate-positive cells increased, suggesting a role of proteasomes and phosphorylation in removing mutated keratin. In contrast, aggregates were reduced by pretreatment with two chemical chaperones, trimethylamine N-oxide (TMAO) and 4-phenylbutyrate (4-PBA). TMAO also modulated stress-induced p38/c-jun N-terminal kinase (JNK) activation and expression of heat shock protein (HSPA1A), the latter of which colocalized with phosphorylated keratin 5 in EBS cells. Taken together, our findings suggest therapeutic targets for EBS and other keratinopathies.
单纯型大疱性表皮松解症(EBS)是一种由角蛋白基因突变(KRT5 或 KRT14)引起的水疱性皮肤病,目前尚无治疗方法。在严重 EBS 患者的培养角质细胞中可见到错误折叠的突变角蛋白聚集体。在其他蛋白折叠障碍中,分子伴侣和泛素-蛋白酶体系统的参与可能会改变疾病的严重程度。在这项研究中,研究了热应激对来自两名 EBS(KRT5)患者和一名健康对照者的永生化细胞中角蛋白聚集的影响,并在有无各种测试化合物的情况下进行了研究。在所有细胞系中均观察到热诱导(43°C,30 分钟)的聚集物,其数量与供体表型相关。在预先用蛋白酶体抑制剂 MG132 和 p38 有丝分裂原激活蛋白激酶(MAPK)抑制剂 SB203580 预处理的 EBS 细胞中,阳性细胞的聚集比例增加,表明蛋白酶体和磷酸化在去除突变角蛋白中起作用。相比之下,用两种化学伴侣三甲基胺 N-氧化物(TMAO)和 4-苯丁酸(4-PBA)预处理可减少聚集体。TMAO 还调节应激诱导的 p38/c-jun N 末端激酶(JNK)激活和热休克蛋白(HSPA1A)的表达,后者在 EBS 细胞中与磷酸化角蛋白 5 共定位。总之,我们的发现为 EBS 和其他角蛋白病提供了治疗靶点。